Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma

Journal of Urology

Volumn 158, Issue 2, 1997, Pages 338-341

  Pariente, J L ^a   Bordenave, L ^a   Michel, Ph ^a   Latapie, M J ^a   Ducassou, D ^a   Le Guillou, M ^a  

^a NONE

Author keywords

Biological; Bladder neoplasms; Keratin; Tumor markers

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0030790975     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64473-2     Document Type: Article

References (17)

1. van der Gaast, A., Schoenmakers, C. H., Kok, T. C., Blijenberg, B. G., Cornillie, F. and Splinter, T. A.: Evaluation of a new tumour marker in patients with non-small-cell lung cancer: CYFRA 21-1. Brit. J. Cancer, 69: 525, 1994.
2. Rastel, D., Ramaioli, A., Cornillie, F. and Thirion, B.: CYFRA 21-1 a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 multicentre study group. Eur. J. Cancer, 30A: 601, 1994.
3. Niklinski, J., Furman, M., Chyczewska, E., Chyczewski, L., Rogowski, F. and Laudanski, J.: Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer. Eur. Respir. J., 8: 291, 1995.
4. Moll, R., Franke, W. W., Schiller, D. L., Geiger, B. and Krepler, R.: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31: 11, 1982.
5. Bordenave, L., Pariente, J. L., Latapie, M. J., Bareille, R., Janvier, G., Baquey, Ch. and Ducassou, D.: Intérêt du dosage du CYFRA 21-1 pour étudier le comportement de cellules épithéliales en culture. 2nd Immunoanalysis, Eur. Symp. IAES, Lille, France, October 1995.
6. Beyer-Boon, M. E., de Voogt, H. J., van der Velde, E. A., Brussee, J. A. and Schabert, A.: The efficacy of urinary cytology in the detection of urothelial tumors. Sensitivity and specificity of urinary cytology. Urol. Res., 6: 3, 1978.
7. Raab, S. S., Lenel, J. C. and Cohen, M. B.: Low grade transitional cell carcinoma of the bladder. Cancer, 74: 1621, 1994.
8. Ro, J. Y., Staerkel, G. A. and Ayala, A. G.: Cytologic and histologic features of superficial bladder cancer. Urol. Clin. N. Amer., 19: 435, 1992.
9. Devonec, M. and Hijazi, A.: A new concept in the natural history of human bladder cancer based on genetic instability of tumors as evidenced by flow cytometric DNA analysis. In: Clinical Cytometry and Histometry. Edited by G. Burger, J. S. Ploem and K. Goerttler. New York: Academic Press, p. 441, 1987.
10. Bittard, H., Lamy, B. and Billerey, C.: Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer. J. Urol., 155: 1887, 1996.
11. Sarosdy, M. F., deVere White, R. W., Soloway, M. S., Shienfeld, J., Hudson, M. A., Schellhammer, P. F., Jarowenko, M. V., Adams, G. and Blumenstein, B. A.: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol., 154: 379, 1995.
12. D'Hallewin, M.-A. and Baert, L.: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J. Urol., 155: 475, 1996.
13. Stieber, P., Dienemann, H., Hasholzner, U., Fabricus, P. G., Shambeck, C., Weinzierl, M., Poley, S., Samtleben, W., Hofmann, K., Meier, W., Fateh-Moghadam, A. and Muller, C.: Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases. Int. J. Biol. Markers, 9: 82, 1994.
14. Senga, Y., Kimura, G., Hattori, T., Oki, M., Hasegawa, J. and Akimoto, M.: Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of the patients in bladder cancer. Proc. A. U. A. Congress, Las Vegas, NV. J. Urol., part 2, 153: 457A, abstract 913, 1995.
15. Prost, A. C., Houze, P. and Longchampt, M. F.: CYFRA 21-1, a new marker for urologic cancer. Proc. XIème Colloque CORATA, 1994.
16. Desgranchamps, F., Toubert, M., Lubin, R., Rastel, D. et souscomité Tumeurs infiltrantes de vessie du CCAFU: Evaluation de la fraction libre βHCG et du CYFRA 21-1 comme marqueurs sériques des tumeurs de vessie. Proc. Congrès de l'Ass. Française Urol. Prog. Urol., suppl, 5: 36A, abstract P15, Paris, France, 1995.
17. Iles, R. K., Persad, R., Trivedi, M., Sharma, K. B., Dickinson, A., Smith, P. and Chard, T.: Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer. Brit. J. Urol., 77: 61, 1996.